Product Overview
20(S)-Ginsenoside Rg3 | T3402 | TargetMol Chemicals
CAS: 14197-60-5
Smiles: CC(C)=CCC[C@](C)(O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@@H]3CC[C@@]21C
Formula: C42H72O13
Pathway: Angiogenesis|||Immunology/Inflammation|||JAK/STAT signaling|||Membrane transporter/Ion channel|||Metabolism|||Neuroscience|||NF-Κb|||Tyrosine Kinase/Adaptors
Target: EGFR|||Beta Amyloid|||Potassium Channel|||NF-κB|||COX|||Sodium Channel|||Endogenous Metabolite
Receptor: N/A
Bioactivity: Ginsenoside Rg3 possess an ability to inhibit the lung metastasis of tumor cells via inhibition of the adhesion and invasion of tumor cells. It inhibits the proliferation of human umbilical vein endothelial cells(HUVEC) and has anti-angiogenesis activities.
Molecular Weight: 785, 025
